STAMFORD, Conn. (AP) _ Cara Therapeutics Inc. (CARA) on Tuesday reported a loss of $17.2 million in its second quarter.

On a per-share basis, the Stamford, Connecticut-based company said it had a loss of 52 cents.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 50 cents per share.

The biotechnology company posted revenue of $2.9 million in the period.

Cara shares have climbed 47 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $17.97, an increase of 20 percent in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CARA at